Ra Medical Systems Stock Price - RMED

Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
$52.04
Small Cap Pro
Monthly Subscription
for only
$49.05
DDE w/Realtime (Monthly)
Monthly Subscription
for only
$34.10
VAT not included
Company Name Stock Ticker Symbol Market Type
Ra Medical Systems Inc RMED NYSE Common Stock
  Price Change Change Percent Stock Price High Price Low Price Open Price Close Price Last Traded
  -0.0705 -4.55% 1.4795 1.59 1.45 1.56 1.55 16:14:55
Stock Trades Traded Volume VWAP Dollar Volume Average Volume 52 Week Range
92 11,418 $ 1.50 $ 17,111 39,951 1.06 - 10.4276
Last Trade Time Type Quantity Stock Price Currency
18:29:41 100 $ 1.4795 USD

Ra Medical Systems Financials

Market Cap Shares in Issue Profit/Loss Earnings Per Share (EPS) PE Ratio Float
$ 19.13M 12.93M $ -30.83M -2.88 - 12.03M
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
165.45k $ - 0.00% - 6.90%

more financials information »

Ra Medical Systems News

Loading Messages....

Latest RMED Messages

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical RMED Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week1.601.701.331.5516,836-0.1205-7.53%
1 Month1.381.8551.281.5227,8620.09957.21%
3 Months1.801.901.061.4967,972-0.3205-17.81%
6 Months4.825.001.062.0071,443-3.34-69.3%
1 Year8.2210.42761.064.0083,485-6.74-82.0%
3 Years21.5022.001.066.9298,204-20.02-93.12%
5 Years21.5022.001.066.9298,204-20.02-93.12%

Ra Medical Systems Description

Ra Medical Systems Inc is a commercial-stage medical device company. It is engaged in designing, developing, and commercialization of excimer lasers for the treatment of dermatologic and cardiovascular diseases. The company's products include DABRA and Pharos. DABRA System is an effective, and versatile catheter and excimer laser system for the treatment of complex and diffuse arterial blockages in the lower vessels, and the Pharos is a monochromatic, xenon-chlorine, 308-nm UVB excimer laser for the treatment of difficult-to-treat, chronic diseases including psoriasis and vitiligo. Its business segments are the Dermatology segment and the Vascular segment. The key revenue is derived from the Dermatology segment.


Your Recent History
NYSE
RMED
Ra Medical..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.